1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Legend Biotech Corporation

Legend Biotech Corporation

LEGN
Legend Biotech CorporationUS flagNASDAQ
23.54
USD
+0.33
- -
4.35BMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
49
57
75
69
117
285
627
1,029
+ Sales & Services Revenue
49
57
75
69
117
285
627
1,029
- Cost of Revenue
- -
- -
- -
- -
65
144
235
408
+ Cost of Goods & Services
- -
- -
- -
- -
65
144
235
408
Gross Profit
- -
- -
75
69
52
141
393
621
+ Other Operating Income
-49
-57
- -
- -
- -
- -
- -
- -
- Operating Expenses
64
193
302
461
507
669
702
757
+ Selling, General & Admin
4
32
73
150
174
201
284
342
+ Research & Development
61
162
232
313
336
382
414
415
+ Other Operating Expense
- -
-2
-3
-2
-2
86
4
1
Operating Income (Loss)
-15
-135
-227
-392
-456
-528
-310
-136
- Non-Operating (Income) Loss
-13
-5
81
15
-10
-8
-151
146
+ Interest Expense, Net
-6
-4
-3
- -
3
-33
-40
-19
+ Interest Expense
- -
- -
- -
1
11
22
22
21
- Interest Income
6
5
3
1
8
54
61
40
+ Other Non-Op (Income) Loss
-7
-1
84
15
-13
25
-112
165
Pretax Income
-2
-130
-308
-407
-446
-520
-158
-283
- Income Tax Expense (Benefit)
1
3
-42
-4
1
-2
19
14
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-3
-133
-266
-404
-446
-518
-177
-297
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-3
-133
-266
-404
-446
-518
-177
-297
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-133
-266
-404
-446
-518
-177
-297
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-3
-133
-266
-404
-446
-518
-177
-297
EBIT
-15
-135
-227
-392
-456
-528
-310
-136
EBITDA
-13
-130
-217
-378
-437
-510
-288
-108
EBITDA Margin (%)
-27.25
-227.21
-289.15
-549.75
-373.68
-178.74
-45.93
-10.46
EBITA
-15
-135
-227
-392
-456
-528
-310
-136
Gross Margin (%)
100
100
100
100
44.14
49.42
62.6
60.34
Operating Margin (%)
-30.68
-236.39
-302.39
-569.97
-389.4
-185.23
-49.34
-13.27
Profit Margin (%)
-5.67
-232.21
-355.16
-586.38
-381.48
-181.8
-28.22
-28.85
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
2
5
10
14
18
18
21
29
Basic Weighted Avg Shares
100
100
118
141
159
176
183
184
Basic EPS, GAAP
-0.03
-1.33
-2.25
-2.87
-2.81
-2.94
-0.97
-1.61
Basic EPS from Cont Ops
-0.03
-1.33
-2.25
-2.87
-2.81
-2.94
-0.97
-1.61
Diluted Weighted Avg Shares
100
100
118
141
159
176
183
184
Diluted EPS, GAAP
-0.03
-1.33
-2.25
-2.87
-2.81
-2.94
-0.97
-1.61
Diluted EPS from Cont Ops
-0.03
-1.33
-2.25
-2.87
-2.81
-2.94
-0.97
-1.61

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
327
207
594
950
1,099
1,498
1,284
1,247
+ Cash, Cash Equivalents & STI
216
159
506
882
1,026
1,309
1,123
949
+ Cash & Cash Equivalents
210
83
456
689
786
1,278
287
902
+ ST Investments
6
76
50
193
240
31
836
47
+ Accounts & Notes Receiv
109
36
83
59
45
157
125
250
+ Accounts Receivable, Net
26
30
75
50
- -
100
6
13
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
82
6
8
8
44
57
119
237
+ Inventories
1
1
2
2
10
19
24
32
+ Raw Materials
1
1
2
2
7
13
18
24
+ Work In Process
- -
- -
- -
- -
1
3
4
1
+ Finished Goods
- -
- -
- -
- -
3
3
2
7
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
11
4
7
19
13
12
16
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
102
81
128
170
232
351
386
487
+ Property, Plant & Equip, Net
33
75
112
143
162
190
202
402
+ Property, Plant & Equip
34
80
123
160
187
225
245
456
- Accumulated Depreciation
1
5
11
17
25
35
44
54
+ LT Investments & Receivables
- -
- -
- -
5
- -
4
4
5
+ LT Investments
- -
- -
- -
5
- -
4
4
5
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
69
5
16
22
70
157
180
80
+ Total Intangible Assets
- -
5
3
17
69
155
174
75
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
5
3
17
69
155
174
75
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
69
- -
13
5
1
1
6
5
Total Assets
429
288
722
1,119
1,331
1,849
1,670
1,734
+ Payables & Accruals
118
80
114
140
227
160
226
298
+ Accounts Payable
7
10
5
7
32
30
37
81
+ Accrued Taxes
75
- -
9
10
11
9
24
27
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
37
71
100
123
184
121
164
189
+ ST Debt
- -
1
1
1
4
3
5
326
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
319
+ ST Finance Leases
- -
1
1
1
4
3
5
7
+ Other ST Liabilities
40
46
- -
88
67
53
47
12
+ Deferred Revenue
40
46
- -
- -
- -
53
47
11
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
88
67
- -
- -
1
Total Current Liabilities
159
128
116
229
298
216
278
636
+ LT Debt
4
5
2
122
281
325
346
87
+ LT Borrowings
- -
- -
- -
120
261
281
301
- -
+ LT Finance Leases
4
5
2
2
20
44
45
87
+ Other LT Liabilities
257
278
7
2
8
55
6
8
+ Accrued Liabilities
257
278
6
2
8
55
6
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
1
- -
- -
- -
- -
8
Total Noncurrent Liabilities
261
283
9
124
289
381
352
95
Total Liabilities
420
411
124
354
587
597
630
732
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
4
4
708
1,261
1,657
2,637
2,696
2,750
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
4
4
708
1,261
1,657
2,637
2,696
2,750
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
6
-127
-117
-520
-966
-1,485
-1,662
-1,958
+ Other Equity
-2
-1
- -
5
15
44
-68
122
Equity Before Minority Interest
9
-123
598
766
744
1,251
1,041
1,002
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
9
-123
598
766
744
1,251
1,041
1,002
Total Liabilities & Equity
429
288
722
1,119
1,331
1,849
1,670
1,734
Shares Outstanding
259
259
266
308
330
364
367
370
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
4
6
3
3
24
47
49
95
Net Debt
-210
-83
-456
-568
-525
-996
14
-583
Net Debt to Equity
-2,429.95
67.85
-76.23
-74.22
-70.55
-79.62
1.39
-58.16
Tangible Common Equity Ratio
2
-45.31
82.71
67.94
53.52
64.73
57.91
55.9
Current Ratio
2.05
1.62
5.14
4.14
3.69
6.92
4.62
1.96
Cash Conversion Cycle
- -
- -
- -
- -
16.99
28.28
13.34
-23.46

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-2
-130
-308
-407
-446
-520
-158
-283
+ Depreciation & Amortization
2
5
10
14
18
18
21
29
+ Non-Cash Items
-11
-10
99
33
45
181
-26
247
+ Stock-Based Compensation
1
1
5
20
34
48
69
65
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
4
- -
+ Other Non-Cash Adj
-12
-12
94
13
11
133
-99
182
+ Chg in Non-Cash Work Cap
319
52
-23
162
181
-73
18
-93
+ (Inc) Dec in Accts Receiv
208
-4
-45
25
50
-99
94
-6
+ (Inc) Dec in Inventories
-1
- -
-1
- -
-14
-13
-17
-4
+ (Inc) Dec in Prepaid Assets
-3
-4
3
-3
-51
-9
-62
-127
+ Inc (Dec) in Accts Payable
22
34
23
143
192
-53
58
80
+ Inc (Dec) in Other
93
26
-4
-2
3
101
-54
-37
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
308
-83
-223
-198
-201
-393
-144
-100
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-21
-39
-30
-45
-22
-23
-14
-29
+ Acq of Fixed Prod Assets
-21
-39
-26
-42
-21
-20
-14
-29
+ Acq of Intangible Assets
- -
-1
-4
-3
-1
-3
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
462
623
378
584
- -
- -
+ Increase in Capital Stock
- -
- -
462
623
378
584
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
-6
-70
26
-148
-40
214
-782
777
+ Dec in LT Investment
- -
321
98
230
615
5,077
1,930
5,320
+ Inc in LT Investment
-6
-390
-73
-378
-655
-4,863
-2,712
-4,543
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
-75
50
-19
-2
-15
-98
-54
-39
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-102
-59
-24
-195
-77
93
-851
710
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
-5
-3
-1
-3
-4
-4
-4
+ Cash From Debt
- -
3
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
-8
-3
-1
-3
-4
-4
-4
+ Other Financing Activities
3
20
159
5
3
212
10
3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
3
15
619
627
378
791
6
- -
Effect of Foreign Exchange Rates
- -
- -
1
- -
-3
1
-2
6
Net Changes in Cash
208
-127
372
233
100
491
-989
609
EBITDA
-13
-130
-217
-378
-437
-510
-288
-108
EBITDA Margin (%)
-27.25
-227.21
-289.15
-549.75
-373.68
-178.74
-45.93
-10.46
Free Cash Flow
287
-122
-253
-244
-224
-416
-158
-129
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-127
-252
-242
-225
-417
-162
-132
Free Cash Flow per Basic Share
2.86
-1.22
-2.14
-1.73
-1.41
-2.36
-0.86
-0.7
Price/Free Cash Flow
- -
- -
-17.26
-42.89
-44.35
-28.59
-45.8
-55.97
Cash Flow to Net Income
-110.52
0.62
0.84
0.49
0.45
0.76
0.81
0.34
Capital Expenditures
-21
-39
-30
-45
-22
-23
-14
-29